ATS awarded US $24 million assignment for biotechnology automation
CAMBRIDGE, ON, Nov. 29 /CNW/ - ATS Automation Tooling Systems Inc. today announced it has been awarded repeat orders totaling approximately US$24 million (CDN $28 million) to manufacture specialized process automation for a leading biotechnology manufacturing company.
The customer is scheduled to take delivery of this advanced automation in numerous stages beginning in March 2006 and concluding in September 2006. This automation - which takes advantage of ATS standard technology - will be manufactured in the Company's North American operations and deployed at the customer's facilities in the United States and Asia. The customer name and further details could not be provided because of customer confidentiality.
"Securing this order is very rewarding to ATS not only because of its size, but because the customer is strategic to us," said Ron Jutras, ATS President and Chief Executive Officer. "It operates in one of the high-growth areas of healthcare, it's a leader in its field and is a repeat customer. We intend to build our future on customers like this who value our industry- leading knowledge of automation, our technology, and our ability to serve their needs on a global basis."
ATS Automation Tooling Systems Inc. (www.atsautomation.com) is the industry's leading designer and producer of turn-key automated manufacturing and test systems, which are used primarily by multinational corporations operating in a variety of industries including: healthcare, automotive, computer/electronics and consumer products. ATS is also an emerging leader in the rapidly growing market for solar energy cells and modules. The Company also makes precision components and subassemblies using process knowledge and automation technology. ATS employs approximately 4,000 people at 26 manufacturing facilities in Canada, the United States, Europe and Asia-Pacific. The Company's shares are traded on The Toronto Stock Exchange under the symbol ATA.
Certain forward-looking statements are made in this news release, including statements regarding possible future results and business. Investors are cautioned that such forward-looking statements involve risks and uncertainties. The Company's results could differ materially from those currently anticipated due to a number of factors including, but not limited to, the risks and uncertainties contained in the Company's fiscal 2005 MD&A and annual report and other risks detailed from time to time in ATS's periodic reports filed with Canadian regulatory authorities.
For further information:
Carl Galloway, VP Treasurer
Gerry Beard, VP, CFO